Regeneron Pharmceuticals (NASDAQ:REGN), MicroStrategy (NASDAQ:MSTR), Qlik Tech (QLIK) and Perry Ellis (NASDAQ:PERY) all had rating initiated on them from several brokerages.
Regeneron Pharmceuticals (REGN) has coverage resumed on them from Boenning & Scattergood, which started them off with an "Outperform" rating. They placed a price target of $58 on REGN.
MicroStrategy (MSTR) had coverage initiated on them by BMO Capital Markets, which started them off with an "Outperform.' They have a price target of $180 on MicroStrategy.
Qlik Tech (QLIK) also had coverage initiated on them by BMO Capital Markets, receiving a "Market Perform" rating from them. They placed a price target of $29 on Qlik.
Deutshe Bank (NYSE:DB) initiated coverage on Perry Ellis (PERY), starting them off with a "Buy" rating.
No comments:
Post a Comment